Otonomy, Inc. announced the appointment of Anthony J. Yost as chief commercial officer. Mr. Yost brings 30 years of experience in pharmaceutical product sales and marketing that includes building and managing commercial teams at multiple companies. Mr. Yost has a track record in developing and implementing successful commercialization strategies in the life science industry including repeat experience in building and managing sales and marketing teams, and launching more than 20 new products.

He joins Otonomy after serving as chief commercial officer for Prometheus Laboratories and EKR Therapeutics. Mr. Yost has also held various commercial and general management positions at Schering-Plough, Boehringer Mannheim Pharmaceuticals and Eli Lilly and Company.